← Eichor
Study identifier: NCT03812718 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Comparison of Anaesthesia Requirement for Ventilation With Endotracheal Tube Versus Proseal Laryngeal Mask Airway

Condition: Cholelithiases · Cholecystolithiasis  ·  Sponsor: Sir Ganga Ram Hospital

PhaseNA
Planned participants160
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

Endotracheal tube (ETT) is the gold standard conduit for providing controlled ventilation during general anaesthesia (GA). however, the supra-glottic airway (SGA) devices in particular the laryngeal mask airway (LMA) and its variants have become a reliable alternative to ETT for carrying out controlled ventilation. Of the several variants of LMA available today, the proseal LMA (PLMA) is preferred for controlled ventilation. The various advantages of LMA includes, a lower incidence of postoperative sore throat and superior haemodynamic profile during surgery. However, one aspect of providing anaesthesia with LMA compared to ETT is the ability of LMA to maintain equivalent depth of anaesthesia with lower anaesthetic requirement, is quiet intriguing and evidence to this regard is very limited. By measuring the anaesthesia requirement using a robust computerised delivery system such as the closed loop anaesthesia delivery system (CLADS) we can establish for sure the anaesthesia required for maintaining intraoperative mechanical ventilation with the use of these two (ETT and PLMA) airway management devices. This randomised controlled study aims to calculate the anaesthesia requirement as determined by the total amount of propofol consumed for maintaining anaesthesia with ETT versus PLMA

This description comes directly from the study's public registry record.

Talk to the study team

Nitin Sethi, DNB  ·  00919717494498  ·  nitinsethi77@yahoo.co.in

Amitabh Dutta, MD  ·  +911142252523  ·  duttaamiatbh@yahoo.co.in

Always discuss trial participation with your own doctor first.

Locations (1)

Sir Ganga Ram HospitalNew Delhi, National Capital Territory of Delhi, IndiaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03812718